ARCHIVES

In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State

This article is from The Cancer Letter archive.

Vol. 19 No. 31 | July 30, 1993

Download PDF Visit The Full Archive

Related Articles

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999

In Brief: NCI Study Finds No Relation Of Fluoridated Water To Cancer Incidence In U.S. Counties

December 5, 1975

In Brief: Middle East Cancer Consortium Formed; Armitage, Mayer Elected To ASCO Positions

May 24, 1996